Microcrystalline Cellulose Market: Size, Growth, Trends & Forecast

The microcrystalline cellulose market is expanding steadily as pharmaceutical, food and beverage, personal care, and other industries increasingly adopt cellulose-based functional ingredients. Microcrystalline cellulose (MCC) is a refined, partially depolymerized form of cellulose derived primarily from wood pulp and plant fibers. It is valued for its binding, stabilizing, bulking, compressibility, and anti-caking properties.

According to Kings Research, the global microcrystalline cellulose market was valued at USD 1,117.6 million in 2023 and is projected to grow from USD 1,175.7 million in 2024 to USD 1,791.0 million by 2031, registering a CAGR of 6.20% from 2024 to 2031. Growing pharmaceutical production, rising demand for functional food ingredients, and increasing consumer preference for plant-based and clean-label formulations are supporting market expansion.

What Is Microcrystalline Cellulose?

Microcrystalline cellulose is a purified cellulose material produced through the controlled processing of cellulose-rich plant sources. It is widely used as a functional ingredient because of its excellent physical and chemical properties.

In pharmaceutical formulations, MCC is commonly used as a tablet binder, bulking agent, and excipient. Its compressibility and stability make it particularly suitable for oral solid dosage formulations.

Beyond pharmaceuticals, MCC is used in food and beverages as a stabilizer, bulking agent, and anti-caking ingredient. It is also gaining adoption in personal care and cosmetics, paints and coatings, and other industrial applications.

Key Factors Driving the Microcrystalline Cellulose Market

Growing Demand for Pharmaceutical Excipients

The expanding pharmaceutical industry is one of the most important factors driving demand for microcrystalline cellulose. MCC plays a critical role in tablet and capsule formulations by improving binding, uniformity, stability, and disintegration.

The increasing prevalence of chronic conditions such as cardiovascular diseases, diabetes, and cancer is contributing to higher demand for pharmaceutical products. As drug manufacturers develop more effective and stable oral dosage formulations, the need for high-performance excipients is increasing.

MCC is particularly valuable in pharmaceutical manufacturing because it can support consistent tablet production and improve formulation performance. The pharmaceutical segment is projected to reach USD 480.0 million by 2031, highlighting its importance to the overall market.

Rising Demand for Clean-Label and Plant-Based Ingredients

Consumer preferences are shifting toward products containing recognizable, plant-based, and sustainable ingredients. This trend is creating opportunities for microcrystalline cellulose across food, cosmetics, and pharmaceutical applications.

Because MCC is derived from cellulose obtained from plant sources, it can support manufacturers seeking alternatives to certain synthetic additives. The growing focus on clean-label formulations is therefore encouraging companies to explore MCC as a functional ingredient.

The trend is particularly relevant in food and personal care products, where consumers increasingly consider ingredient origin and formulation transparency when making purchasing decisions.

Expansion of Food and Beverage Applications

The food and beverage industry represents another important application area for MCC. Its functional properties allow manufacturers to use it in formulations requiring stabilization, bulking, texture improvement, and anti-caking performance.

Increasing demand for processed foods, convenience products, and functional food formulations is creating additional opportunities for cellulose-based ingredients.

As manufacturers continue to reformulate products to meet changing consumer preferences, MCC is expected to benefit from demand for functional and plant-derived ingredients.

Microcrystalline Cellulose Market Trends

Shift Toward Sustainable Raw Materials

Sustainability is becoming increasingly important throughout the cellulose industry. Manufacturers are exploring alternative sources of cellulose, including agricultural residues and other non-wood sources, to reduce dependence on traditional wood pulp.

These developments can help diversify raw material supply while supporting more sustainable production models.

Technological improvements in cellulose extraction and processing are also helping manufacturers improve production efficiency and explore new feedstocks.

Development of High-Performance Pharmaceutical Excipients

Pharmaceutical manufacturers are increasingly seeking excipients that can improve formulation stability, manufacturing efficiency, and drug performance.

This is encouraging suppliers to develop specialized MCC grades and co-processed excipients designed for specific formulation requirements. Improvements in moisture protection and direct-compression performance are particularly important for modern pharmaceutical manufacturing.

In October 2023, Roquette introduced new moisture-protection excipients aimed at addressing stability challenges in moisture-sensitive drug formulations.

Growth of Non-Wood-Based Cellulose

Although wood-based MCC remains dominant, non-wood sources are gaining attention as manufacturers seek to diversify their raw material supply.

Agricultural residues and other plant-based materials can provide alternative cellulose sources while potentially improving supply-chain resilience. This development could become increasingly important as manufacturers seek to reduce exposure to fluctuations in wood pulp availability and pricing.

Microcrystalline Cellulose Market Segmentation

The global market is segmented based on source, form, application, and region.

By Source

The market is divided into:

• Wood based
• Non wood based

The wood-based segment generated USD 646.8 million in revenue in 2023. Its dominance is supported by widespread availability, high purity, cost-effectiveness, and strong binding and stabilizing properties. Wood-derived MCC remains widely used in pharmaceutical and food applications.

However, non-wood sources are expected to receive increasing attention as companies focus on sustainable sourcing and supply diversification.

By Form

Based on form, the market is categorized into:

• Powdered
• Liquid

The powdered segment accounted for 54.76% of the market in 2023. Powdered MCC is widely preferred because it is easy to handle and offers strong compressibility, making it particularly suitable for pharmaceutical solid dosage formulations.

The segment is projected to reach USD 979.7 million by 2031.

By Application

The market is segmented into:

• Pharmaceutical
• Food & beverages
• Personal care & cosmetics
• Paints & coatings
• Others

Pharmaceutical applications represent a major growth opportunity due to increasing drug production and demand for high-quality excipients. Food and beverage applications are also expected to benefit from growing interest in clean-label and functional ingredients.

Personal care and cosmetics manufacturers are increasingly exploring MCC for formulations aligned with demand for plant-based and sustainable products.

Regional Outlook

North America

North America held the largest regional share of the global microcrystalline cellulose market in 2023, accounting for 33.78%, with a market valuation of approximately USD 377.6 million.

The region benefits from its established pharmaceutical and food industries, advanced healthcare infrastructure, strong research and development activities, and stringent quality requirements for pharmaceutical excipients.

The United States represents a major contributor to regional demand due to its large pharmaceutical manufacturing base and significant consumption of processed and functional foods.

Asia Pacific

Asia Pacific is expected to be the fastest-growing regional market, with a projected CAGR of 7.12% during 2024–2031.

Growth is supported by expanding pharmaceutical manufacturing, increasing healthcare investment, rising disposable income, and growing demand for functional food and cosmetic products.

China, India, and Japan are among the important markets in the region. The availability of raw materials, expanding manufacturing capabilities, and increasing investments in healthcare infrastructure are expected to create significant opportunities for MCC suppliers.

Europe

Europe remains an important market due to its established pharmaceutical, food, and personal care industries. Regulatory requirements and increasing demand for high-quality, sustainable ingredients are encouraging manufacturers to focus on compliant and environmentally responsible MCC products.

The region's emphasis on sustainability and clean-label formulations is expected to support demand for plant-derived cellulose ingredients.

Challenges in the Microcrystalline Cellulose Market

Despite positive growth prospects, the market faces challenges related to raw material dependency and supply-chain disruptions.

Wood pulp and other plant-derived raw materials can experience fluctuations in availability and pricing. Disruptions in raw material supply can affect production costs and create challenges for manufacturers.

To address these risks, companies are exploring alternative sources such as agricultural residues and microbial cellulose. Regional manufacturing facilities and diversified supplier networks can also improve supply-chain resilience.

Regulatory compliance is another important consideration, particularly for pharmaceutical and food applications. Manufacturers must meet strict quality, safety, and formulation requirements across different markets.

Competitive Landscape

The global microcrystalline cellulose market includes established multinational companies as well as specialized regional manufacturers. Companies are competing through product development, capacity expansion, sustainable sourcing, partnerships, and geographic expansion.

Major companies identified by Kings Research include Fengchen Group Co., Ltd., International Flavors & Fragrances Inc., Ankit Pulps and Boards Pvt Ltd., Asahi Kasei Corporation, Roquette Frères, Sigachi Industries, SEPPIC, FMC Corporation, DFE Pharma, Vivion, and JRS PHARMA, among others.

Manufacturers are increasingly focusing on high-purity MCC, organic and non-GMO variants, improved pharmaceutical excipients, and sustainable production technologies.

In January 2023, Asahi Kasei completed its second Ceolus microcrystalline cellulose plant at Mizushima Works in Japan, expanding production capacity to meet growing demand from pharmaceutical and food industries.

Future Outlook

The microcrystalline cellulose market is expected to maintain steady growth through 2031 as demand increases across pharmaceuticals, food and beverages, personal care, and other industries.

The market's projected growth from USD 1.1757 billion in 2024 to USD 1.7910 billion by 2031 reflects the expanding role of MCC as a functional and versatile cellulose-based ingredient.

Future opportunities are likely to emerge from:

• Sustainable and non-wood cellulose sources
• Clean-label food formulations
• Plant-based personal care products
• Advanced pharmaceutical excipients
• High-performance powdered MCC
• Regional production expansion
• Improved cellulose processing technologies

Asia Pacific is expected to remain a particularly attractive growth region, while North America will continue to benefit from strong pharmaceutical and food industry demand.

Conclusion

The microcrystalline cellulose market is benefiting from the growing pharmaceutical industry, rising demand for functional food ingredients, and increasing preference for plant-based and clean-label formulations. Its versatile properties make MCC an important ingredient across pharmaceutical, food, personal care, and industrial applications.

With the global market projected to reach USD 1.791 billion by 2031 at a CAGR of 6.20%, manufacturers that focus on sustainable sourcing, product innovation, regulatory compliance, and supply-chain resilience are well positioned to capitalize on future opportunities.